Nagene specializes in the production of custom DNA sequences through advanced gene synthesis technologies. We serve the pharmaceutical and biotechnology sectors, providing precise, high-quality DNA products that support research, development, and therapeutic applications, including mRNA therapies and personalized medicine.
R&D:Nagene’s current research focus is minimal, as our gene synthesis process is fully developed. However, we are continuously improving and optimizing this process. In 2025, our main research efforts will be dedicated to the innovative Cell-Free project, marking a significant shift in our research activities.
Production:Nagene specializes in fast and reliable gene synthesis with an industry-leading TAT of just 5 days. Our production follows stringent GMP standards, ensuring the highest quality and safety for pharmaceutical and biotech applications. With state-of-the-art facilities and cutting-edge technology, we guarantee precision and consistency in every DNA sequence we produce, supporting personalized therapies and innovative treatments.
Services:Nagene provides flexible, customer-oriented gene synthesis services with the highest quality standards. Every order includes optional quality documentation such as CoA and CoC, with all production following GMP-compliant batch records. We ensure personalized support throughout, offering tailored solutions to meet your specific needs efficiently and reliably.
Sales/Distribution:Nagene's sales efforts include active participation in key industry conferences such as BIO-Europe and SynBio Markets. Our LinkedIn business page and website provide continuous updates, while our dedicated sales team offers personalized support to each customer, ensuring that every need is met efficiently. We work closely with clients, from inquiry to delivery, to guarantee satisfaction and high-quality results.
Christine-Touaillon-Straße 11/2.12, 1220 Vienna, Austria
Vienna
Vienna
Contact:
Telephone: 6641909011
Email: alexander.makula@nagene.at
Website